glp-1 kind patches Patches': Do the Products Influencers Are Selling Work? GLP-1 meds changed the game

The remaining TRIUMPH trials (TRIUMPH-2/-3/-4 and TRIUMPH-Outcomes) have not yet reported and remain anticipated through 20262028

So far, large studies have not shown a consistent or significant increase in pancreatitis risk with semaglutide, tirzepatide, or other GLP-1s compared to placebo

See 21 U.S.C

To understand how the two main options compare and which tends to suit which patient, see our guide on how semaglutide and tirzepatide compare for medically supervised weight loss and which one tends to fit which patient

Dual GLP-1/glucagon receptor agonists, including mazdutide, integrate appetite suppression with increased energy expenditure and fat oxidation, while triple GLP-1/GIP/glucagon agonists, such as retatrutide, further augment these mechanisms through multi-pathway receptor engagement

Declaration of interest C R A and A A declare no conflicts of interest